Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_assertion description "[The promising efficacy results of the Trastuzumab for Gastric Cancer trial led to the approved use of trastuzumab-based therapy as first-line treatment for patients with HER-2+ AGC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_assertion evidence source_evidence_literature NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_assertion SIO_000772 22334453 NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_assertion wasDerivedFrom befree-2016 NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_assertion wasGeneratedBy ECO_0000203 NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP960931.RASlgUrOhsBqQNQ6o9CddQTaF7THzlG0SWMeT8n4AolWQ130_provenance.